23.19MMarket Cap-684P/E (TTM)
2.870High2.860Low204Volume2.850Open2.820Pre Close584.46Turnover0.00%Turnover RatioLossP/E (Static)8.11MShares4.55052wk High0.85P/B15.19MFloat Cap2.51052wk Low--Dividend TTM5.31MShs Float36.720Historical High--Div YieldTTM0.36%Amplitude2.510Historical Low2.865Avg Price1Lot Size
Lumos Pharma Stock Forum
News
Update
Seminar Started
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
Today's trading is a short-seller's fiesta, but long players aren't left in the dust either!
✅ CDIO bucked the trend with a strategic 13.04% LONG MOVE and nimbly dipped 13.99% on the short side!
💥 HSCS is the short sensation, dropping a massive 57.85%!
💣 BIOL, LUMO, and BYU are making waves with short moves of 18.99%, 18.66%, and a whopping 27.34%, respectively!
See you all tomorrow AM for another rou...
bullish
🔔 🔍 Lens Focused, Market Observers! New Day on the Horizon! 🔔
Still energized from YESTERDAY'S 48% LONG MOVE? Let's channel that momentum into today’s action:
✅1️⃣ HSCS Long > 0.5135 Short < 0.4745
✅2️⃣ BIOL Long > 2.01 Short < 1.79
✅3️⃣ LUMO Long > 4.84 Short < 4.61
✅4️⃣ CDIO Long > 1.61 Short < 1.43
✅5️⃣ BYU Long > 3.11 Short < 2.89
Armed with insight, let’s dominate today’s session. Watch this space for our strategic plays! 📈💥
Hehehe
News!
Met All Primary and Secondary Endpoints
Phase 2 Data Provide Supportive Evidence to Advance Oral LUM-201 to Phase 3
•OraGrowtH210 Results Show LUM-201 Dose of 1.6 mg/kg Achieves Annualized Height Velocities (AHV) of 8.2 cm/yr at 6 Months and 8.0 cm/yr at 12 Months, Comparable to Growth Rates for Moderate PGHD Population
•Delta at 6 and 12-month AHV Between Optima...
No comment yet